Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-09 Purchase |
2021-02-09 3:10 pm |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:09 pm |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:08 pm |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
475,000 | $17 | $8,075,000 | 357,353 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 2:55 pm |
Terns Pharmaceuticals Inc. | TERN | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Member of 10% Group 10% Owner |
665,000 | $17 | $11,305,000 | 2,382,033 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-09 Conversion |
2021-02-09 3:10 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
6,632,408 | $0 | 2,274,723 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:09 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
6,632,408 | $0 | 2,274,723 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:08 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner |
3,426,240 | $0 | 357,353 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 2:55 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Member of 10% Group 10% Owner |
1,717,033 | $0 | 2,382,033 (Indirect) |
View |
Ownership |
2021-02-04 5:16 pm |
N/A 2030-08-12 |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
0 | $0 | 949,197 (Direct) |
View |
Ownership |
2021-02-04 5:15 pm |
N/A 2029-01-10 |
Terns Pharmaceuticals Inc. | TERN | Quirk Erin See Remarks |
0 | $0 | 379,678 (Direct) |
View |
Ownership |
2021-02-04 5:14 pm |
N/A 2030-09-09 |
Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer |
0 | $0 | 227,807 (Direct) |
View |
Ownership |
2021-02-04 5:13 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan See Remarks |
0 | $0 | 265,775 (Direct) |
View |
Ownership |
2021-02-04 5:12 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Zhong Weidong Chief Scientific Officer |
0 | $0 | 513,520 (Direct) |
View |
Ownership |
2021-02-04 5:11 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
0 | $0 | 28,475 (Direct) |
View |
Ownership |
2021-02-04 5:10 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director |
0 | $0 | 28,475 (Direct) |
View |
Ownership |
2021-02-04 5:09 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director |
0 | $0 | 28,475 (Direct) |
View |
Ownership |
2021-02-04 5:07 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
0 | $0 | 3,316,204 (Indirect) |
View |
Ownership |
2021-02-04 5:07 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
0 | $0 | 3,316,204 (Indirect) |
View |
Ownership |
2021-02-04 5:05 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,200,133 (Indirect) |
View |
Ownership |
2021-02-04 5:01 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | LAV Biosciences Fund V L.P. Hopewell Resources Holdings Ltd Oriental Spring Venture Ltd LAV Aqua Ltd 10% Owner |
0 | $0 | 4,781,566 (Indirect) |
View |